Leuphasyl vs Acetyl Hexapeptide-3 (Argireline) — Peptide Comparison

At a Glance

Quickcomparison

Dose Range

Leuphasyl

2%–5% %

Acetyl Hexapeptide-3 (Argireline)

5%–10% %

Frequency

Once daily

Administration

Topical

Cycle Length

Ongoing/indefinite

Onset Speed

Moderate (1-2 weeks)

Evidence Level

Limited human trials

Efficacy

Benefitratings

Expression Wrinkle Reduction

Peptide Synergy

Safety & Tolerability

Non-Invasive Treatment

Safety Profile

Technical Data

Compoundspecifications

Molecular Formula

C29H39N5O7

Molecular Weight

569.65 Da

Half-Life

Topical application; sustained neuromuscular effect with twice-daily reapplication

Bioavailability

Topical dermal penetration sufficient for neuromuscular junction modulation in facial skin

CAS Number

64963-01-5

C35H62N14O11S

887.0 Da

Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7

Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery

616204-22-9

Protocols

Dosingtiers

standard

5-10% concentration (cream or serum)

Twice daily (morning and evening)

Minimum 28-30 days; ongoing use to maintain effect

Used as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]

Applications

Bestsuited for

Individuals seeking non-invasive alternatives to botulinum toxin for expression lines

Leuphasyl is particularly well-suited for individuals focused on individuals seeking non-invasive alternatives to botulinum toxin for expression lines. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those wanting to enhance Argireline results through complementary peptide mechanisms

Leuphasyl is particularly well-suited for individuals focused on those wanting to enhance argireline results through complementary peptide mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

People with dynamic wrinkles on the forehead, glabella, and crow's feet areas

Leuphasyl is particularly well-suited for individuals focused on people with dynamic wrinkles on the forehead, glabella, and crow's feet areas. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Users preferring gentle peptide-based wrinkle treatments for sensitive skin

Leuphasyl is particularly well-suited for individuals focused on users preferring gentle peptide-based wrinkle treatments for sensitive skin. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those with needle phobia who want botulinum toxin-like effects without injections

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

People targeting crow's feet, forehead lines, and glabellar creases

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Individuals looking for preventive anti-wrinkle treatment to slow expression line formation

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Sideeffects

Common

Transient Product Sensation

Initial Adjustment Period

Dryness from Vehicle

Reduced Effect Over Time

Uncommon

Contact Sensitivity (very rare)

Serious

Allergic Reaction (theoretical)

Opioid Receptor Cross-Reactivity

Mild Skin Irritation

Transient Redness

Slight Dryness

Stinging on Compromised Skin

Contact Dermatitis

Allergic Contact Dermatitis

Research Status

Safety& evidence

FDA Status

Research compound

Safety Overview

Leuphasyl (a pentapeptide GnRH agonist) carries the safety profile of the GnRH agonist drug class with 40+ years of veterinary and research use. Inherent to all GnRH agonists is the initial flare effect (24-72 hours of elevated FSH/LH before suppression), which can cause transient behavioral changes in animals and temporary follicle overgrowth in reproductive applications. Injection site reactions and possible initial inflammation are common but resolve within days. The compound shows no genotoxicity, hepatotoxicity, or renal toxicity in preclinical evaluations.

Contraindications

xKnown hypersensitivity to Pentapeptide-18 or formulation components

xActive dermatitis or skin infections at intended application sites

xConcurrent use with topical products at extreme pH that may hydrolyze the peptide

xSevere skin barrier compromise in the treatment area

Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. The peptide shows a safety margin of approximately 100-fold compared to toxic reference compounds. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.

xKnown hypersensitivity to acetyl hexapeptide-3 or formulation components

xActive skin infections or open wounds at the application site

xNo known systemic contraindications at cosmetic concentrations

xUse with caution in individuals with neuromuscular disorders (theoretical concern)

Decision Guide

Which isright for you?

Choose Leuphasyl if...

Individuals seeking non-invasive alternatives to botulinum toxin for expression lines

Those wanting to enhance Argireline results through complementary peptide mechanisms

People with dynamic wrinkles on the forehead, glabella, and crow's feet areas

Users preferring gentle peptide-based wrinkle treatments for sensitive skin

Choose Acetyl Hexapeptide-3 (Argireline) if...

Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles

Those with needle phobia who want botulinum toxin-like effects without injections

People targeting crow's feet, forehead lines, and glabellar creases

Individuals looking for preventive anti-wrinkle treatment to slow expression line formation